For example, by triggering receptor expressed on myoid cells-2 (TREM2), CSF-1R is a high risk marker for Alzheimer's disease, which explains the disadvantage of mono targeting CSF-1R from another point of view 85. Here, CSF1R is linked to early-onset autosomal dominant Alzheimer disease.